
Academic Journal
Q2Precision Radiation Oncology
About Precision Radiation Oncology
Precision Radiation Oncology is a scholarly journal published by Wiley-Blackwell Publishing Ltd. SCImago 2025 lists it in Q2, with an SJR of 0.746 and H-index of 14.
Coverage: 2017-2026. Research categories: Oncology (Q2).
Verified field sources
- Editor(s): Jinming Yu (Editor) — Official source; checked 2026-10-03. Editorial leadership listed under Edited By on the Wiley journal homepage; publisher role retained without assuming Editor-in-Chief.
Open-access policies and author information
Reported in the official DOAJ public CSV snapshot (2026-09-01), downloaded 2026-10-03. Record updated 2026-03-17. This snapshot does not establish today’s listing status or fee quotation.
Publisher policy links recorded by DOAJ
- Aims and scope ↗
- Editorial board ↗
- Instructions for authors ↗
- Peer-review policy ↗
- Publication fees ↗
- Fee waivers ↗
- Licence terms ↗
- Copyright policy ↗
- Preservation policy ↗
Source: DOAJ journal record. Journal metadata is distributed by DOAJ under CC0. Confirm current fees, tax, eligibility and waiver terms with the publisher.
Source-backed journal facts
Topics in published research
Advanced Radiotherapy Techniques; Radiation Therapy and Dosimetry; Effects of Radiation Exposure; Lung Cancer Diagnosis and Treatment; Radiomics and Machine Learning in Medical Imaging; Head and Neck Cancer Studies.
OpenAlex classifies topics from published works. These topics are not the publisher’s official aims and scope.
Source: OpenAlex source record. Retrieved 2026-10-03. Source record updated 2026-10-02. OpenAlex metrics are different from SCImago metrics and the Clarivate Journal Impact Factor.
Journal Metrics
Quartile, SJR and the listed SCImago H-index use the 2025 imported SCImago dataset. A quartile may vary by subject category. Values without a source or reporting year are unverified historical entries. Verify the current Journal Impact Factor with Clarivate or the publisher before using it.
Aims & Scope
The publisher’s official aims and scope have not yet been verified for this profile. Use the journal website to check subject fit and accepted article types before submitting.
Recent Research Articles
Latest publications matched automatically by ISSN.
177 Lu‐labeled amidoxime‐functionalized biodegradable microspheres for transarterial radioembolization of hepatocellular carcinoma
Xingliang Liu, Gang Wang, Zhenwen Zhao, Haoyu Wang et al.
2026-09-29 · DOI: 10.1002/pro6.70094Integrated multi‐omics analysis of post‐translational modifications in head and neck squamous cell carcinoma: elucidating x‐ray and carbon ion irradiation effects
Fan‐Tong Xia, Zhi‐Yun Liao, Si‐Qi Cai, Li‐Rong Zhou et al.
2026-09-27 · DOI: 10.1002/pro6.70097The efficacy of concurrent chemoradiotherapy with or without nimotuzumab in high‐risk patients with locally advanced head and neck squamous cell carcinoma post‐surgery: A real‐world study
Yuejia Zhou, Linting Zhang, Wenjuan Lai, Jingyun Tan et al.
2026-09-27 · DOI: 10.1002/pro6.70099Expert consensus on clinical trial design guidelines for FLASH radiotherapy
Hui Luo, Chen Cheng, Chengliang Yang, Bing Li et al.
2026-09-23 · DOI: 10.1002/pro6.70098MR‐Linac Successfully Guided the Treatment of a Free‐Moving Mesenteric Mass
Xin Wang, Tze Yee Lim, He Wang, Bouthaina Shbib Dabaja et al.
2026-09-22 · DOI: 10.1002/pro6.70093C–X–C Motif Chemokine Receptor 4 (CXCR4)‐Targeted Biologically Guided Proton Spatially Fractionated Radiotherapy for Bulky Limited‐Stage Small Cell Lung Cancer
Keru Pu, Tengxiang Li, Shengnan Xu, Xue Sha et al.
2026-09-12 · DOI: 10.1002/pro6.70095Radiation‐free or Chemo‐free: Rethinking the Best Strategy for PD‐L1‐High, Unresectable Stage III NSCLC
Yongbo Xiang, Nan Bi
2026-09-09 · DOI: 10.1002/pro6.70088Issue Information
2026-09 · DOI: 10.1002/pro6.7009618 F‑FAPI‑04 PET/CT imaging of fibroblast activating protein reveals myocardial injury beyond cancer staging
Jing Jia, Chuan Zhou, Shuzhen Yi, Jinsong Zheng et al.
2026-09 · DOI: 10.1002/pro6.70092Precise delineation of radiation targets for thoracic tumors in the immunotherapy era: From immune mechanisms to clinical practice
Xiaoying Chen, Minxiao Yi, Yu Deng, Qian Shen et al.
2026-09 · DOI: 10.1002/pro6.70090Effects of proton therapy on the tumor immune system and clinical implications: A review
Rundong Liu, Mei Tao, Min Fu, Yingjia Hu et al.
2026-09 · DOI: 10.1002/pro6.70089Assessing the influence of microdosimetric formalism on calculations of relative biological effectiveness in carbon ion radiotherapy
Shannon Hartzell, Keith M. Furutani, Alessio Parisi, Tatsuhiko Sato et al.
2026-08-18 · DOI: 10.1002/pro6.70087Exosomal hnRNPA1‐delivered miR‐27a‐3p inhibits the radiation‐induced bystander effect in cervical cancer
Meng‐Qi Yang, Ping Huang, Yun‐Rui Song, Yong‐Zhong Wu et al.
2026-09 · DOI: 10.1002/pro6.70084Synergistic effects and clinical utilization of radioimmunotherapy for brain metastases from driver mutation‐negative non‐small cell lung cancer
Silai Yu, Jianjiao Ni, Hongru Chen, Nuan Weng et al.
2026-09 · DOI: 10.1002/pro6.70085Robustness Evaluation of Physical versus Virtual Bolus for Breast VMAT Using RegGAN‐Based Synthetic CT
Yong Sang, Lingke Kong, Jianan Wu, Junqin Lei et al.
2026-09 · DOI: 10.1002/pro6.70083Normal tissue complication probability models of late cardiopulmonary toxicity following deep inspiration breath hold for breast cancer adjuvant radiotherapy
Lin Lin, Liang Liu, Zhengxin Gao, Yaling Hong et al.
2026-09 · DOI: 10.1002/pro6.70086R3Net: Recursive Residual Refinement Network Architecture for Decoder‐Free Medical Image Segmentation
Jing Huang, Yongkang Zhao, Yuhan Li, Zhitao Dai et al.
2026-09 · DOI: 10.1002/pro6.70082Safety, efficacy, pharmacokinetics, and mechanisms of novel 10 B‐boronophenylalanine combined with a radio‐frequency quadrupole accelerator in boron neutron capture therapy: A preclinical study in head and neck squamous cell carcinoma
Zhaoyuan Zhang, Junyan Li, Minhua Fan, Huafu Ouyang et al.
2026-09 · DOI: 10.1002/pro6.70075Radiotherapy and Immunotherapy In Hepatocellular Carcinoma: Priming the Tumor Immune Microenvironment From Bench To Bedside
Zhigang Fu, Yang Zhang, Zuomin Wang, Zongjuan Li et al.
2026-09 · DOI: 10.1002/pro6.70057Reviews
Community Reviews
Version History
October 2, 2026 at 9:02 pm
October 2, 2026